VIDEO: New treatments on horizon for RA

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify dstatman@healio.com if there are concerns regarding accuracy of the transcription.

Time for patients who have rheumatoid arthritis, because they have options. We have our regular conventional DMARD therapies. We have triple therapy. We have methotrexate, leflunomide, sulfasalazine, hydroxychloroquine. We now have the biologics with really good safety data. We have the targeted synthetic therapies with new ones emerging. In terms of the choices that patients have, the choices that rheumatologists have to present to their patients, this is just such an exciting time for them. In terms of future development, there's quite a few other drugs that are currently in the pipelines for rheumatoid arthritis. These include other JAK inhibitors. There's one in particular, Peficitinib, that's being developed. There's other cytokine inhibitors like IL-6 inhibitors to sirukumab. There's one that's actually very, very interesting, which is a scorpion venom toxin. which is a scorpion venom toxin. It's called (indistinct) toxin. What it does is it inhibits fibroblast-like synoviocytes. There's also gene therapies. The future of RA, who knows. There might be some development there with gene therapies. Great time be a rheumatologist. If you were to have RA now, this is actually an opportunity to be able to go into remission, because that's gonna be the ultimate goal is gonna be remission.